Torrent Pharma has reported a consolidated net loss of
Rs 1.65 crore for the fourth quarter of financial year 2011-12 as against
profit of Rs 42.84 crore in a year ago period.
Consolidated net sales jumped 34.65% to Rs 654 crore in the
quarter ended March 2012 from Rs 486 crore in the corresponding quarter of last
fiscal.
Total expenses increased 28.69% year-on-year to Rs 611.06
crore during the same period.
Torrent Pharma has received one time gain of Rs 65.36 crore
during the quarter due to provision for estimated future sales returns from the
market.
It has decided to pay a total dividend of Rs 8.50/share for
FY12.
On Friday, the stock closed at Rs 632.95, down 1.10% amid
heavy volumes. Trading volumes increased 132% to 3,771 shares as compared to
its 5-day average of 1,627 shares.
Source: www.moneycontrol.com
Thanks,
Gaurav Agarwal
Head Dealer
DENIP Consultants Pvt Ltd
No comments:
Post a Comment